What was claimed

They don't do pre-licensure safety testing for vaccines. They're the only product that's exempt

Our verdict

Inaccurate

FDA and CDC sources state that vaccines undergo extensive animal and human testing for safety before licensure. FDA guidance also describes a typical pre-licensure safety database of at least 3,000 vaccinated participants. Vaccines are not exempt from pre‑licensure review; FDA reviews preclinical, clinical, and manufacturing data for vaccines just as it does for other biologics and drugs. No credible source shows vaccines are uniquely exempt.

Combined assessment17 sourcesChecked Oct 16, 2026

Why this verdict

  • Vaccines are the only product exempt from pre-licensure safety testing.

    Incorrect
    All assessments reached this conclusion
  • They don't do pre-licensure safety testing for vaccines.

    Incorrect
    All assessments reached this conclusion

Evidence reviewed

17 sources

Perplexity, Claude and ChatGPT sources are combined here.

Individual assessments

Assessment summary

  • The response makes a major false claim: vaccines undergo pre-licensure safety testing in laboratory, animal, and human studies resee.it voicesforvaccines.org.
  • Vaccines may not always use an inert placebo, but that does not mean they are exempt from safety testing or uniquely exempt among products resee.it.

Claims reviewed

Vaccines are the only product exempt from pre-licensure safety testing.

Incorrect
Vaccines are not exempt from pre-licensure safety testing; FDA evaluates safety and effectiveness before approval resee.it resee.it. The claim also confuses the absence of an inert-placebo trial for some vaccines with an exemption from safety studies.

This claim may mislead readers without added context.

They don't do pre-licensure safety testing for vaccines.

Incorrect
FDA and CDC sources state that vaccines undergo extensive animal and human testing for safety before licensure resee.it voicesforvaccines.org. FDA guidance also describes a typical pre-licensure safety database of at least 3,000 vaccinated participants factcheck.org.

This claim may mislead readers without added context.

Assessment summary

  • Both major claims in this statement are factually incorrect.
  • Vaccines undergo extensive pre-licensure safety testing including preclinical studies, laboratory testing, animal studies, and multi-phase clinical trials.
  • Vaccines are not exempt from safety testing; they actually receive greater regulatory scrutiny than most other products, including dietary supplements.

Claims reviewed

They don't do pre-licensure safety testing for vaccines

Incorrect
FDA regulations require extensive preclinical testing, animal studies, and multi-phase clinical trials before vaccine licensure. Phase 1, 2, and 3 trials specifically test safety in human subjects.

This claim may mislead readers without added context.

Vaccines are the only product that's exempt from safety testing

Incorrect
Vaccines are among the most heavily tested and regulated products. Many other products like dietary supplements undergo no safety review. Vaccines receive greater scrutiny than most drugs.

This claim may mislead readers without added context.

Assessment summary

  • The statement is incorrect because vaccines undergo defined pre‑licensure safety testing including preclinical studies and phased clinical trials before licensure.
  • Regulatory agencies (FDA, CDC) require and review preclinical and Phase 1–3 clinical safety and efficacy data prior to approval, so vaccines are not exempt from pre‑licensure safety testing.

Claims reviewed

They're the only product that's exempt.

Incorrect
Vaccines are not exempt from pre‑licensure review; FDA reviews preclinical, clinical, and manufacturing data for vaccines just as it does for other biologics and drugs. No credible source shows vaccines are uniquely exempt. fda.gov fda.gov

This claim may mislead readers without added context.

They don't do pre-licensure safety testing for vaccines.

Incorrect
Vaccines require preclinical testing and phased human clinical trials (Phase 1–3) that evaluate safety before licensure; regulators review these data as part of approval. fda.gov cdc.gov

This claim may mislead readers without added context.

Check your own claim

Paste any statement, headline, or AI answer. Independent assessments check it and compare sources.

Share this result